Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
- PMID: 19683034
- DOI: 10.1016/j.brainresbull.2009.08.004
Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
Abstract
There has been growing interest in the axon as the initial focus of pathological change in a number of neurodegenerative diseases of the central nervous system. This review concentrates on three major neurodegenerative conditions--amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease--with emphasis on key cellular changes that may underlie early axonal dysfunction and pathology and, potentially, the degeneration of neurons. In particular, this review will address recent data that indicate that the main pathological stimuli for these conditions, though often not definitively determined, result in an initial perturbation of the axon and its cytoskeleton, which then results in slow neuronal degeneration and loss of connectivity. The identification of a degenerative process initiated in the axon may provide new therapeutic targets for early intervention to inhibit the grim outcomes related to the progression of these diseases.
Similar articles
-
Protecting axons in multiple sclerosis.Mult Scler. 2008 Sep;14(8):1013-25. doi: 10.1177/1352458508091370. Epub 2008 Jul 16. Mult Scler. 2008. PMID: 18632772 Review.
-
Oxidative stress and neurotoxicity.Chem Res Toxicol. 2008 Jan;21(1):172-88. doi: 10.1021/tx700210j. Epub 2007 Dec 4. Chem Res Toxicol. 2008. PMID: 18052107 Review.
-
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.Exp Neurol. 2010 Jul;224(1):92-102. doi: 10.1016/j.expneurol.2010.03.030. Epub 2010 Mar 29. Exp Neurol. 2010. PMID: 20353778 Review.
-
Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis.Exp Neurol. 2013 Aug;246:6-13. doi: 10.1016/j.expneurol.2013.05.001. Epub 2013 May 9. Exp Neurol. 2013. PMID: 23664960 Review.
-
Inflammation and degeneration in multiple sclerosis.Neurol Sci. 2003 Dec;24 Suppl 5:S265-7. doi: 10.1007/s10072-003-0170-7. Neurol Sci. 2003. PMID: 14652785 Review.
Cited by
-
SYK coordinates neuroprotective microglial responses in neurodegenerative disease.Cell. 2022 Oct 27;185(22):4135-4152.e22. doi: 10.1016/j.cell.2022.09.030. Epub 2022 Oct 17. Cell. 2022. PMID: 36257314 Free PMC article.
-
The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.Cells. 2023 Jan 27;12(3):420. doi: 10.3390/cells12030420. Cells. 2023. PMID: 36766763 Free PMC article. Review.
-
The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease.Neurosci Bull. 2011 Oct;27(5):287-99. doi: 10.1007/s12264-011-1736-7. Neurosci Bull. 2011. PMID: 21934724 Free PMC article.
-
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.Exp Brain Res. 2012 Apr;217(3-4):353-64. doi: 10.1007/s00221-011-2870-1. Epub 2011 Sep 30. Exp Brain Res. 2012. PMID: 21960299 Free PMC article. Review.
-
Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models.Front Neuroanat. 2013 Sep 26;7:30. doi: 10.3389/fnana.2013.00030. eCollection 2013. Front Neuroanat. 2013. PMID: 24133416 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical